A Prospective Cohort Study of the Impact of Sarcopenia on Prognosis in Patients with Pancreatic Cancer

Prospective Cohort Study of the Impact of Sarcopenia on Prognosis in Patients with Pancreatic Cancer - Prospective Cohort Study of the Impact of Sarcopenia on Prognosis in Patients with Pancreatic Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050510

Enrollment

140

Registered

2023-03-10

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unresectable pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients = or >18 years of age 2) unresectable pancreatic cancer based on CT scan findings 3) pathological diagnosed invasive ductal carcinomas 4) ECOG performance status 0 or 1 4) patients of first-line chemotherapy introduced for unresectable pancreatic cancer

Exclusion criteria

Exclusion criteria: 1) patients with active multiple primary cancer 2) patients with pacemakers

Design outcomes

Primary

Measure	Time frame
1-year progression free survival rates	—

Secondary

Measure	Time frame
1-year overall survival rates prognostic risk factor adverse event	—

Countries

Japan

Contacts

Public ContactKosuke Okuwaki

Kitasato University School of Medicine Department of Gastroenterology

kokuwaki@kitasato-u.ac.jp+81-42-778-8111

Outcome results